Passiflora Incarnata Flower Extract.

Both are used in evening formulas for a calm-alertness effect without a stimulant load. Passionflower flavonoids are reported to act at GABA-A binding sites, while theanine is reported to raise alpha-band cortical activity and to modulate glutamate signalling. The two may arrive at a similar felt outcome through different receptor routes, which is why they are stacked. Human data on the specific combination is thin, so read this as mechanistic rather than clinical.

Magnesium is a physiological modulator of NMDA receptor activity and a cofactor in over three hundred enzymatic steps, including those that support normal nervous system function. Glycine itself is an inhibitory neurotransmitter at its own receptor. Paired with passionflower's GABA-A activity, the combination covers two distinct inhibitory routes. The pairing is formulation convention rather than a tested combination.

Valerian and passionflower have appeared together in European herbal preparations for well over a century. Both are reported to interact with GABAergic signalling, valerian through valerenic acid at the beta subunit and passionflower through its flavone fraction. Anyone combining them should expect the calming effect to stack rather than cancel. Caution applies alongside anything else that promotes drowsiness.

Lemon balm contributes rosmarinic acid, which inhibits GABA transaminase and so slows the breakdown of GABA already present. Passionflower works at the receptor end of the same system. The two are long-standing partners in tea blends and tinctures aimed at evening calm. The rationale is pharmacological overlap, not a head-to-head trial.

Chamomile's apigenin is a benzodiazepine-site ligand at GABA-A, and passionflower extracts carry chrysin and related flavones with affinity for the same complex. Stacking them raises total flavone load at one receptor family. That is a reason to start low rather than to assume a bigger effect is better. The combination is common in sleep-support blends.

Apigenin is one of the flavones present in Passiflora incarnata itself, so supplementing it alongside a standardised extract raises the dose of a compound the extract already delivers. Both act at the benzodiazepine binding site of GABA-A without being benzodiazepines. Total flavone exposure, not the label count, is what changes. This is straightforward additive chemistry.

Melatonin acts on MT1 and MT2 receptors to shift circadian timing, a different axis from passionflower's GABAergic calming. Sleep formulas commonly pair a timing signal with a calming agent because they address separate parts of falling asleep. Drowsiness effects add together. Neither ingredient substitutes for the other.

Supplemental GABA is the endogenous ligand for the receptor that passionflower flavones modulate. How much oral GABA reaches central receptors remains contested, so the pairing rests on the receptor logic rather than on established central delivery. Passionflower does not depend on the added GABA to act. Read the combination as speculative in humans.

Glycine is an inhibitory neurotransmitter at its own strychnine-sensitive receptor and a co-agonist at NMDA receptors, and it lowers core body temperature in the evening. Passionflower contributes GABA-A modulation. The two inhibitory systems are separate, which is the basis for combining them. Effects on drowsiness add.

Tryptophan is the dietary precursor for serotonin and downstream melatonin, a supply-side route that is unrelated to receptor modulation. Passionflower acts on the receptor side of the inhibitory system. Formulators combine a precursor with a modulator because the two act at different points. Anyone already taking a serotonergic medicine should raise the combination with a clinician.

5-HTP sits one enzymatic step downstream of tryptophan and bypasses the rate-limiting hydroxylase. Passionflower contributes no serotonergic precursor of its own. The pairing joins a substrate route to a receptor route. Serotonergic loading is the reason to be careful when other serotonergic agents are in use.

Honokiol and magnolol from magnolia bark are positive modulators at GABA-A, overlapping directly with the passionflower flavone fraction. Two positive modulators at one receptor complex is a genuine additive load. Evening formulas pair them for that reason. Sedation effects stack and should be accounted for.

Ashwagandha withanolides act largely through the hypothalamic-pituitary-adrenal axis and cortisol rhythm, a slow endocrine route measured over weeks. Passionflower acts acutely at receptors within an evening. Combining a slow axis-level agent with an acute one is a common formulation shape. They are not redundant.

Rhodiola is generally used for daytime stimulation and monoamine modulation, which pulls in the opposite direction from passionflower's evening calming. Some formulas use rhodiola in the morning and passionflower at night in one regimen. Taken together at the same hour the two may partly offset. Timing, not exclusion, is the practical point.

Caffeine is an adenosine receptor antagonist that raises central arousal, the opposite direction from GABA-A positive modulation. Taken close together the arousal signal will blunt the calming one. This is a well-understood pharmacological opposition, not a hazard. Separating them by several hours is the usual approach.

St John's wort is a potent inducer of CYP3A4 and P-glycoprotein and alters plasma levels of many co-administered compounds. Passionflower's flavonoid constituents undergo phase I and phase II handling that induction can accelerate. The interaction runs on the metabolic side rather than the receptor side. Anyone taking prescription medicines should clear this pairing with a clinician first.